A novel theranostic activity-based probe targeting kallikrein 7 for the diagnosis and treatment of skin diseases.
Chem Commun (Camb)
; 57(53): 6507-6510, 2021 Jul 07.
Article
em En
| MEDLINE
| ID: mdl-34105530
We applied a new in silico approach for using protease-substrate motifs to design a kallikrein 7 (KLK7)-specific phosphonate activity-based probe (ABP) to quantify the active KLK7 in situ. Epidermal application of the ABP-inhibitor on Spink5-/-Klk5-/- mice, a Netherton syndrome model, reversed disease hallmarks, providing preclinical proof-of-concept for using ABPs as theranostics.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dermatopatias
/
Simulação por Computador
/
Calicreínas
/
Sondas Moleculares
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article